In vivo activation of the PI3K-Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetes.
about
EGFR signaling promotes β-cell proliferation and survivin expression during pregnancyMig6 haploinsufficiency protects mice against streptozotocin-induced diabetesEpidermal Growth Factor Receptor Signaling Regulates β Cell Proliferation in Adult Mice.Inhibition of progression of PanIN through antagonizing EGFR.Cellular signaling pathways regulating β-cell proliferation as a promising therapeutic target in the treatment of diabetes
P2860
In vivo activation of the PI3K-Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
In vivo activation of the PI3K ...... 58R protects against diabetes.
@en
In vivo activation of the PI3K ...... 58R protects against diabetes.
@nl
type
label
In vivo activation of the PI3K ...... 58R protects against diabetes.
@en
In vivo activation of the PI3K ...... 58R protects against diabetes.
@nl
altLabel
In vivo activation of the PI3K ...... 858R protects against diabetes
@en
prefLabel
In vivo activation of the PI3K ...... 58R protects against diabetes.
@en
In vivo activation of the PI3K ...... 58R protects against diabetes.
@nl
P2093
P2860
P1433
P1476
In vivo activation of the PI3K ...... 58R protects against diabetes.
@en
P2093
Décio L Eizirik
Elina Hakonen
Hannu Sariola
Jarkko Ustinov
Timo Otonkoski
P2860
P2888
P304
P356
10.1007/S00125-014-3175-2
P407
P577
2014-02-04T00:00:00Z